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Abstract Henrietta Lacks died of cervical cancer in 1951 at 31, but a cell line 
from her tissues is still alive and reproducing for scientific purposes. Her dramatic 
biography and her fundamental (although unwitting) contribution to the 
development of scientific knowledge went unnoticed until Rebecca Skloot's "The 
immortal life of Henrietta Lacks" [New York, Random House, 2010, 384 pp.] was 
published. The political, scientific, social and technological entanglement of 
Henrietta's account by Skloot is an original and vivid science narrative of clear 
relevance for Science and Technology Studies. Stemming from Henrietta's story 
and Skloot's book, Stefano Crabu, Mauro Turrini, Marialuisa Lavitrano and Sara 
Casati reflect and discuss on the relation between society and medical research, 
its ethical dilemmas, as well as on the way technoscientific processes can be 
accounted for. 
 




HeLa Cells: a Biomedicine Keystone and its Ethical 
Dilemmas 
Marialuisa Lavitrano and Sara Casati 
 
 
Scientists know her as HeLa but she was Henrietta Lacks. Mother of 5 children 
from a poor Afro-American family, she was 31 years old, when she discovered she 
had a malignant epidermoid carcinoma of the cervix (cervical cancer) from which 
she died some months later. During her radiation treatments, two samples of her 
cervix were removed — a healthy part and a cancerous part — without her 
consent, so that she never knew that her cells became a cell line that would be 
widely used in science. Then, as now, there was no requirement to inform a 
patient, or their relatives, about such matters because discarded material, or 
material obtained during surgery, diagnosis, or therapy, was the property of the 
physician and/or medical institution (currently this requires ethical approval and 




The cells from Henrietta Lacks cervix were processed by a researcher, George 
Gey, who discovered that they were something extraordinary: they were different, 
they could be kept alive and grow. Before this, cells cultured from other cells 
would only survive for a few days. The cells from Henrietta's tumour reproduced 
an entire generation every 24 hours and never stopped. HeLa cells have an highly 
altered genetic asset, characterized by supernumerary and/or modified 
chromosomes (they have got a chromosome number of 82, with four copies of 
chromosome 12 and three copies of chromosomes 6, 8 and 17): this asset makes 
unique Hela cells. These were the first human "immortal" cells ever grown in a 
laboratory: they do not die after a few cell divisions; they could be propagated 
indefinitely in vitro; they can divide an unlimited number of times in a laboratory 
cell culture plate as long as fundamental cell survival conditions are met; they were 
not subjected to senescence; they could be frozen and thawed and used in various 
ways. The infection with human papilloma virus 18 had modified an enzyme: this 
enzyme elongated the telomeres after chromosomes are copied, so the cells could 
multiply continuously. These cells would become the HeLa immortal cell line, a 
commonly used cell line in biomedical research. They proved to be an invaluable 
resource for scientific research. 
George Gey distributed them to other scientists across the world to experiment. 
Gey freely donated both the cells and the tools and processes his lab developed to 
any scientist requesting them, simply for the benefit of science. By 1954, the HeLa 
strain of cells was being used by Jonas Salk to develop a polio vaccine. To test 
Salk's new vaccine, the cells were quickly put into mass production in the first-ever 
cell production factory. Demand for the HeLa cells, at this point, quickly grew. 
HeLa cells were sent to many scientists to perform research into cancer, AIDS, the 
effects of radiation and toxic substances. They also went up in the first space 
missions to see what would happen to cells in zero gravity. At the origin of the first 
cloning experiments and vitro-fertilization, the cells have furthered our 
understanding of cancer, HIV and cell physiopathology in general, and are still 
extensively used to grow viruses and to test anti-tumour medicines. For instance 
Tamoxifen, one of the first anticancer drugs, was based on them. The cells were 
later commercialized. It has been estimated that the total number of HeLa cells 
that have been propagated in cell culture far exceeds the total number of cells that 
were in Henrietta Lacks' body. Scientists have grown some 20 tons of her cells and 
at present more than 74.000 scientific papers have been published and there are 
almost 11.000 patents involving HeLa cells. 
Until a few years ago no one knew the history of Henrietta; Rebecca Skloot 
investigated and told it to us. Before, the Lacks family never understood how the 
cells would be used and that was not explained to them. This led to a lot of anxiety 
and strain on the family: Henrietta’s son were subjected to long observations and 
analysis from scientists 
 They were exposed to unwanted intrusion and attention, they were under the 
eyes of all without knowing it and without being able to choose.  
Behind a human cells line there is an individual with his/her story, with his/her 
family and the future generations: the process of naming cell lines has changed 




since the 1950s to prevent people finding out who cells come from. Today, cell 
lines are anonymized so they can’t be traced back to a named person. But the 
Lacks’ family were harmed by the use of their mother’s tissue for research and 
much is made about the fact that neither Henrietta Lacks or her family was asked 
for permission to use her tissue in research.  
Lack of informed, explicit consent and confidentiality can generate important 
consequences on people involved and Lacks’ story shows that in no circumstance it 
might be ethically admissible to use residual tissue (collected for other clinical 
purposes) in research without asking permission: it makes more vulnerable 
individuals at stake, it would harm them. This is due to the nature of the samples, 
and their “relational” nature as we said before. This starts up a second set of 
bioethical and public policy questions, and not just about the kind of consent 
required (from patient, from family, from both?). 
The big question is: do the tissues belong to someone? And related: to whom 
do the financial benefits generated from research belong? 
The Lacks family were unable to afford healthcare in the USA. Henrietta Lacks, 
as she was African American, had to travel miles to a segregated hospital to be 
treated. And racial discrimination and the resulting partial access to care deserve a 
separate discussion. 
George Gey did not profit from the cells when he sent them to other scientists. 
Yet, some pharmaceutical businesses cultured HeLa cells and have profited by 
their manufacture and continue to make lots of money. At the same time, Lacks 
family has remained profoundly poor.  
Many researchers, institutions, and companies have benefited from the HeLa 
cells, but the family did not receive anything in return for their “donation”. This 
was and continues to be the norm in research in the USA (a precedent set in case 
law by Moore versus Regents of University of California that research subjects do 
not have property interests in their body parts and are not owed any 
compensation). This model has influenced also the European perspective. 
We could have a society in which people freely “donate” their tissue to research 
without expectation of compensation because of an understanding that the 
treatments and cures that result will benefit us all. We can share that we are 
together in the development of science and committed to the common good. But it 
is also clear to us that for it to work, it needs to be fair. We should imagine 
circumstances where benefit sharing might be an obligation and compensation 
goes back to collectivity at least: we need an open conversation on this. 
 
Post scriptum: one of the things we do not want people to take from the story of 
HeLa cells is the idea that tissue sampling and cell culture are bad. So much of 
medicine today depends on this. Instead of saying we do not want that to happen, we 







Immortal Cells and a Dead Woman. On attempting to 





Rebekka Skloot’s The Immortal Life of Henrietta Lacks is much more than a 
well-documented and captivating reconstruction of one of the most prominent 
achievements of the 20th century life sciences: the creation of the first immortal 
human cell line ever grown outside of an organism. The attempt to cross the 
enormous gap between the two main (human and “non-human”) actors of this 
scientific event makes this a poignant work for the STS audience.  
The scientific saga begins with a cervical cancer biopsy, whose cells proliferated 
with “a mythological intensity” in the artificial environment created in the 
laboratory. But this story has also another protagonist, Henrietta Lacks, a cancer 
patient who died eight months after some doctors snipped a piece of tissue from 
her cervix in the Johns Hopkins hospital ward for “coloured” people, without her 
knowledge or consent. The official storyline tells the remarkable success of this 
clinic in establishing a human immortal cell line in vitro, whose role in the life 
sciences of the 20th century cannot be overemphasized. The other less known 
storyline introduces us to a vivacious 31 years-old Afro-American woman, who left 
a tobacco farm to move to a poor area on the outskirts of Baltimore, where she 
lived with her five children. On the one hand, a living technology known, bought, 
sold and shipped to labs all around the world. On the other, the sudden, 
precocious death of a woman who, due to the suspect of being a victim of sorcery, 
did not receive a proper burial rite and was forgotten by her true relatives.  
Skloot tries to unveil the human costs hidden in this story. This leads the reader 
to discover unexpected ramifications of science in social arenas, such as those of 
economically disadvantaged African-American communities. The relevance of 
political questions, such as racism and human tissue ownership, is one of the 
driving forces of this gripping non-fiction science narrative. Undoubtedly, Skloot 
succeeds in raising important questions for a larger public audience. However, her 
story has many pitfalls, regarding both her relationship with the victims whom she 
intends to reward, and the ways in which the debated questions are framed. She 
intends to compensate for the systematic misconduct of science, but her attempt to 
bridge or at least reduce the enormous gulf between medical research and society 
is lacking. 
 
1. There is no available information about Henrietta Lacks, apart from one 
black and white picture, which usually appears in biology textbook captioned just 
with her name (which is sometimes the wrong one). As a college student in 




biology, Skloot perceives this puzzling empty space in the story of such an 
important medical achievement. Once become a science journalist, this 
indifference leads her to an indefatigable ten-years quest for the hidden story of 
“the woman in the photograph”. Since Henrietta Lacks did not leave many traces 
behind, Skloot decides to turn to her husband and descendants. In a brilliant 
example of extra-academic, creative use of ethnography, Skloot gains the trust of 
this family and, particularly, of Deborah, Henrietta’s daughter. Along with her, 
Skloot identifies the social environment where Henrietta Lacks and her family had 
lived growing up. The reader is brought through a weird and fascinating journey 
made up of ex-slaves, semi-abandoned villages of tobacco farmers in Virginia, poor 
industrial African American neighbourhoods, old asylums for black people, and 
top class hospitals and laboratories. Deborah’s and the Lacks’ memories, opinions 
and beliefs are used to provide an evocative perspective through which one can 
reconsider biomedicine and scientific research.  
From the Lacks’ point of view, the HeLa story is presented as a scientific and 
medical crime. At its core lies the social, economic and cultural distance between 
medical researchers and patients and their relatives, who in this case have been 
persistently and deliberately kept away from this story. In this regard, it is very 
interesting to note that George Gey – considered “the father” of HeLa (in the 
traditional version of this story) – did plot to keep the identity of the donor as 
secret. When the cells met with success, he decided not only to release an invented 
name to the press, Helen Lane, but also demanded that his colleagues and 
collaborators use the fake. Only after his death was permission given to his 
assistant to release Henrietta’s real name, but she never did. Neither of them had 
economic interests in the HeLa cells, since they had never been patented. 
However, they actively wanted to keep the family away from them. The Lacks 
became acquainted with HeLa twenty years after Henrietta’s death, due to the 
initiative of a young reporter in search of a scoop. Some years later, Johns Hopkins 
laboratory researchers contacted the Lacks, but not to provide information about 
their relative. They wanted blood samples of Henrietta Lacks’ children. In that 
period the contamination of hundreds of HeLa cell lines around the world was 
discovered, and so a more detailed genetic characterization of the HeLa cells was 
required to determine exactly which cells were contaminated. During this 
operation, the Lacks family was provided with no information regarding Henrietta 
Lacks, HeLa cells or the purpose of the tests they were doing. Moreover, the 
Lacks’ genetic profiles were later published in scientific journals without any 
consent.  
Skloot does intend not only to criticize the deliberate strategy of Johns Hopkins 
to breach any bound of fairness and even respect. She also tries to provide relief 
for the recurrent violations and persistent exploitation that the troubled family had 
undergone for half a century. In the final chapters of the book, the two different 
stories of HeLa and the Lacks seem to merge together. Thanks to Skloot’s 
dedication, Deborah and her brother Zakaryia are invited by a prominent biologist 
to visit the HeLa cells in the Johns Hopkins laboratory. They saw “their mother’s 




which they preserve with care and pride. This episode is an emotionally intense 
passage. At the same time, it evokes a pacification and a new understanding 
between Johns Hopkins and the Lacks which could be metaphorically expanded to 
the relationship between biomedicine and society. However, some of the political 
indications it offers are at best ambiguous. 
 
2. Even if the Lacks are at the core of the narrative, the politics implied by 
scientific practice makes this book much more than a portrait of the emotional 
ordeals of the Lacks family. I think that both the richness and the limits of this 
book can be found in the ways in which these issues are approached. The relevance 
of racism is contextualized as a general issue of U.S. medical research in the 
decades after the World War II. Until fifty years ago many American hospitals did 
not accept African Americans, and others, such as Johns Hopkins, did so only in 
special wards for “coloured”. In the same period, there were several cases of 
exploitation of black people as experimental subjects, including cruel clinical 
experimentation whose meaninglessness recalled Nazi experiments on Jews.  
Another means used to articulate the issue of racism is the parallel between 
Henrietta and her family. Their opinions, beliefs and practices in daily life offer a 
unique perspective on American biomedicine that Skloot describes vividly with all 
of their contradictions. For example, Skloot recalls a recurrent tale in black oral 
history that she overhears in a family conversation, which tells of black people 
kidnapped by “night doctors” for research. Another racial familiar episode that the 
Lacks experienced regards the asylum where Henrietta Lacks’ eldest daughter 
lived and died, called tellingly “the hospital for the negro insane”. The author also 
decides to visit this ex-clinic (currently abandoned) along with Deborah.  
The evocative conflation of Henrietta Lacks and her family history leads Skloot 
not only to denounce the systematic racism in biomedicine, but also to discover an 
authentic, intimate description of Henrietta Lacks. The HeLa cells story is 
presented not only as a scientific crime, but also as the personification/animation 
of Henrietta Lacks. HeLa cells are considered as an inestimable, although 
involuntary, gift to science, which confers Henrietta Lacks immortality. In an 
attempt at authenticity, Skloot is particularly concerned with the Lacks’ deviations 
– sex abuse, drug, prison, illness, and eating disorders. Unfortunately, relating 
these dysfunctions to Henrietta Lacks’ exploitation, Skloot loses tracks of 
Henrietta and her relatives as full human beings. At one and the same time, the 
personification of the cells as an immortal entity has obscured Henrietta Lacks, as 
Landecker (2000) points out, as well as, we can add, her family. If the characters 
within the family are not fabricated, they are surely “made up” (Littlefield and 
Pollock 2011), in that they are entirely functional to Skloot’s narrative framework. 
Even if in the course of the book the author describes well the contradictory 
and multifaceted feelings, emotions and judgements of the Lacks, at the end and at 
the beginning she mentions these opinions which completely agree and support 
her journalistic, scientific mission. In a fine example of bad ethnography, in the 
final words of the book, the voice of Sonny, one of Henrietta’s children, is literary 
ventriloquized.  




“I don’t want to cause problems for science”, Sonny told me as the book went to press. “Dale 
wouldn’t want that. And besides, I’m proud of my mother and what she done for science. I just hope 
Hopkins and some of the other folks who benefited off her cells will do something to honour her and 
make right with the family” (Skloot 2010, 328). 
Finally, Skloot’s personal perseverance, which led her heroically through the 
poor, uneducated and even threatening black side of America, has been finally 
rewarded. She is able to bring conclusion to her initial goal: to redeem the racial 
violence of medical research, by honouring Henrietta Lacks and making right with 
the family. Publicizing an “otherwise-hidden-and-lost” story of racism seems to 
work as a way to make the family understand the scientific importance of their 
mother, and to withdraw their aversion to medical science and especially to Johns 
Hopkins. However, in its concern to hail the benefits of science (and scientific 
journalism), the book turns out to contribute to Henrietta Lacks’ and her family’s 
invisibility and, so, to dismiss the contemporary relevance of racism. It is striking, 
for example, that Skloot does not mention those Americans who earn a life by 
volunteering as an experimental subject moving from clinic to clinic. Moreover, 
racism is now become a globalized phenomenon in medical research. The 
outsourcing of services to off-shore locations regards also clinical trials, which are 
used by developing countries such as India as a major avenue to become a global 
player in medical biotechnologies (Sunder Rajan 2006).  
 
3. The second issue raised by Skloot deals with the economic dimension of 
Henrietta Lacks’ unwitting donation. Skloot presents the situation as an ironic 
contradiction between the scientific and economic relevance of both Johns 
Hopkins and the HeLa cells, and a family living poverty. As Deborah Lacks-
Pullum (quoted in Skloot 2010, 9) puts it:  
I always have thought it was strange, if our mother cells done so much for medicine, how come 
her family can’t afford to see no doctors? Don’t make sense. People got rich off my mother without 
us even known about them taking [sic] her cells, now we don’t get a dime.  
As opposed to how she deals with racism, which she discards as a rather 
obsolete problem, Skloot frames tissue ownership and patentability as a growing 
contemporary issue, where human tissues have become the raw material in the 
expanding industry of medical biotechnologies. In particular, she uses the 
Afterword to explain why the issue of property and patentability of human tissue 
does not regard uniquely the Lacks family, but has become an urgent, general 
question within the fast-pace development of biotechnologies. In the course of the 
book, she also describes the landmark case of John Moore, a patient with 
leukaemia whose cancer was developed into a cell line that was patented and 
commercialized. John Moore took legal action against the Medical Centre where 
he was treated, but the Supreme Court of California rejected any claim of 
extending any propriety rights on human tissue for the fear of hampering medical 
research. Commenting on this sentence, Skloot underlines that the expropriation 
of human tissue is not just about scientific and medical progress, but also interests 




patent, buy, and sell cell lines as well as other human bodily parts. Tissue 
collections, once treated as special waste, are nowadays an extremely profitable 
source in biomedical industry and research. Thus, Skloot recognizes the 
contradiction implied in the two opposing economic regimes that govern the 
exchange of human bodily parts either as gifts or as commodities. However, her 
emotional, sensationalistic approach to the HeLa ends up narrowing her 
perspective based on the (improbable) claim of economic rewards for Henrietta 
Lacks’ descendants. Actually, as shown clearly by Catherine Waldby and Robert 
Mitchell (2006), in contemporary ownership the double movement of public 
expropriation and private appropriation of human tissue (organs, blood, cells, and 
even DNA fragments) is continually subject to the regulation of biomedical 
research and health service. The extension of patentability to engineered human 
tissue has to be understood as part and parcel of a more general extension of 
intellectual property rights to an ever-increasing number of objects, including 
human tissue.  
We do not intend here to defend the sentence against John Moore, but rather 
to reconsider this unwitting donation as part of a more general interchange 
between medicine and society. It seems to me more interesting to understand the 
relentless request for patients’ bodily parts as health-related information as a new 
form of labour, a “clinical labour” (e.g. Turrini 2011), which is as necessary for the 
bio-economy as workers’ activities are for the manufacturing industry. Insisting on 
economic compensation for the Lacks’ family seems to me a rather blind 
perspective, especially after John Moore’s case. It is not by accident that the 
character who originally endorsed it, was a fake lawyer who dogged the Lacks 
family for several years and who is harshly criticized as a recidivist cheater. Skloot 
herself does not seem to really believe that the Lacks should be economically 
rewarded by Johns Hopkins. In general, her criticism works well as a literary 
strategy that highlights the ironic parallel between biomedical grand achievements 
and socially disadvantaged people. However, it does not respond adequately to the 


















We are so crafty: we make bio(s) immortal! Or the 




Doctors took her cells without asking. Those cells never died. They launched a medical 
revolution and a multimillion-dollar industry. More than twenty years later, her children 
found out. Their lives would never be the same (The Immortal Life of Henrietta Lacks, 
by Rebecca Skloot). 
 
Luisa is a junior researcher. She works as a contract employee for an Italian public 
institute, which is leader in the research and treatment of neoplasia. Together with three 
colleagues, Luisa is setting up a new laboratory of molecular biology. Luisa’s glowing face 
bursts into the room that houses the experimental bio-analytical activities. She turns to 
Gina, who is a laboratory technician well respected by the colleagues: “We have got our 
line immortalized: the flasks are full and the little cells look indeed beautiful to me. Do I 
put away a part of HeLa to test the carbon nanotubes?”. Gina smiles, she nods a “yes” 
and puts back into the fridge her DNA samples (Author’s fieldnotes). 
 
 
Nothing seems more uprooted from the technoscientific repertoire than the 
concept of immortality, which is often considered a characteristic topos of the 
mythological and romantic fictions and it is usually evoked and related to diabolic 
pacts (i.e. Dorian Gray and Devil) and divination activities (i.e. the meeting 
between Ulysses and Circe). This topos, which uses either the grammars of 
superstition, of alchemy, or of paganism and religion, is able to confer an endless 
vital feature to biological substances and bodies that would be exposed to the time, 
contamination, disease and death. However, immortality was not only narrated. In 
fact, alchemy – whose proto-scientific experimental grammar founded modern 
Chemistry – has been cultivating without success the project of materialization of 
immortality. According to some legend, the Philosopher's Stone has been 
considered along the ages to have the property to revive eternal youth to body’s 
erosion (Tenney, 1934). Therefore, it should be noted that these grammars do not 
properly fit with what Ludwik Fleck has defined as scientific practice of “thought-
style” (Fleck, 1979). 
However, in 1951 something relevant happened: science, and in particular 
biomedicine and life sciences, began to address the concept of immortality, or 
better to say of “immortalization”. As Rebecca Skloot – who is specialized in the 
field of science narrative writing – reported in her novel The Immortal Life of 
Henrietta Lacks (2010), what really happened during the 1950's was certainly not a 
pact with the devil. It was, rather, a successful innovation that even today, as it 
emerges from the opening fieldnotes, still affects the life of thousand of 




centres which clinically experiments the most innovative possibilities offered by 
biotechnologies for treating neoplastic pathologies. The emblematic story, which is 
narrated in Rebecca Skloot's novel, belongs to the not so distant 1951, when in the 
United States of America the racial segregation and the Ku Klux Klan had a 
significant impact on the political and the social arenas. During those post war 
years, the Rockefeller Foundation lavished massive financial investments in the 
dawning molecular biology, which supported the American research program from 
1932 to 1959 with 25 million dollars. 
Rebecca Skloot' s novel is focused on Mrs. Henrietta Lacks, a poor Afro-
American farmer who worked in the tobacco fields like her enslaved ancestors and 
then died at the Johns Hopkins Hospital of Baltimore, in Maryland, because of an 
aggressive cervical cancer. The Johns Hopkins Hospital, which was founded in 
1889 as a charity hospital for the caring of indigent people, was ranked one of the 
best hospitals in the United States of America. This prestigious institution was 
located just a few kilometres from Henrietta’s house; besides, it was the only 
institute within a hundred kilometres radius that accepted Afro-American patients. 
At that time it was not common to speak openly about cancer, even if fifteen 
thousands American women died every year because of the same disease that 
tormented Henrietta. For many years biomedical scientists had been trying to test 
samples of malignant cells in order to monitor their growth in vitro, that is outside 
the human body, with the aim to give a valuable contribution to the research on 
the oncogenesis and cancer treatment. In carrying out this task, they attempted to 
discover a procedure which allowed the human cells to become immortal, to 
continuously reproduce themselves and never die. George Gey, director of the cell 
culture laboratory at the Johns Hopkins Hospital – who loved to define himself as 
“the world’s most famous vulture, feeding on human specimens almost constantly” 
(Lacks, p. 46) – had been trying to grow some cells thirty years, but all of his 
attempts systematically failed. 
Just before Henrietta died, a doctor named Richard Wesley TeLinde – who in 
1951 was involved in a heated controversy regarding the treatments of uterine 
tumours at the Hopkins Centre – took, without any authorization, a sample of 
tumorous tissue from her uterine cervix in order to give it to George Gey’s wife; 
then, that sample was put on culture inside a Petri capsule containing some 
chicken blood. This praxis became routine and it was repeated several times either 
without success or the donor's consensus. One day an extraordinary event 
occurred, Henrietta Lacks’ cells began to multiply, showing an unprecedented 
resistance to contaminations; these outcomes not only demonstrated that 
Henrietta’s tumorous tissue could become immortal, but also contributed to 
transform and innovate the procedures through which the biosciences have been 
conducting clinical experimentations and researches. 
Thanks to research work which lasted 10 years, Rebecca Skloot has 
reconstructed the genealogy of the first and most important immortal human cells, 
namely “HeLa”, which are the initial letters of Henrietta Lack's first name and 
surname. Surprisingly, the author of this novel is not a STS scholar, as currently 
intended in the academic world. Arguably she might be described as a “STS 




spontaneous scholar” for the way in which she was able to restore the linkages 
between the cultural, social and technoscientific dimensions which have allowed 
HeLa to become a fundamental technological infrastructure within the 
biotechnological field. The HeLa cells, due to the centrality in biomedical 
laboratory experiments, have acquired the features of a situated technology. In 
fact, the HeLa cell line represents a relational infrastructure that supports the work 
of biologists, clinicians and researchers. Such an infrastructure is the 
"biotechnological background" and "pathological model" par excellence in which 
cancer research is articulated even today, structuring the experimental activities of 
bioresearches and enclosing laboratory routines (Star, 1999). 
It is worth noting that HeLa cells represent one of the main progresses of 
biomedicine, such as the detection of the polio vaccine, the definition of the new 
chemotherapy regimens, the cloning and the mapping of the human genome, the 
in vitro fertilization as well as the venturing into outer space to study behaviour of 
human cells in the absence of gravity. Those same “immortal” cells have travelled 
from 1951 to the XXI century crossing laboratories and research centres 
throughout the continents, as well as the most recent convergence with 
nanotechnologies, which are considered the last frontier in the fight against cancer. 
Skloot’s book is a complex “novel” where the author – mirroring the fashion in 
which Michel Foucault described the history of insanity in the age of reason 
(Foucault, 1961) – never uses the concept of “immortalized cancer cell lines” as a 
category of intelligibility. This is a style of investigation that eschews the banal 
historical reductionism, which consists in studying social phenomena with 
universal categories that are often taken for granted, and not put in question in 
their historical process. 
In this way, Rebecca Skloot has observed the biographies, the life stories and 
the biotechnological objects (medical records, biopsies, cells, test tube, chemical 
reagents, etc.) in order to track a common technoscientific subtext, which is tagged 
as HeLa only at the end of a long stabilization process. Thus, it emerges a precise 
theoretical and methodological statement – peculiar to Foucault’s genealogical 
approach (Foucault, 2004) – which consists in assuming that there are no universal 
categories taken for granted (the disease, oncologist, patients with cancer, cells, 
DNA, etc.), which the traditional sociological analysis, like the historical one, 
usually adopts to account the processes of technological innovation. On the 
contrary, in the text historical sources and data are examined to identify whether 
these, in their process and historical convergence, return something that might be 
definable as "immortal human cells". In other words, the genealogy of situated 
practices is preferred as a lens to interpret the process of biotechnology innovation, 
instead of using universal categories such as grids of intelligibility required to 
deduce some concrete phenomena. 
Rebecca Skloot's text works both on the analytical or the narrative level, and 
these two dimensions which apparently seem to be distant surprisingly here are 
masterly interwoven. In fact, the plot manages to link together two different 
biographical levels: on the one hand, there is Henrietta Lacks’ biography, and on 




which is characterized by an ineffable epistemological statute. The final result 
emerges from an implosion of nature/culture (Haraway, 1997), as a sort of 
“cyborgbiography” of the first immortal human cells. This biography, where the 
biological element is constantly compared and entangled with the technological 
object, is constructed through a symmetrical and relational narrative style that goes 
beyond technicalities and focuses also on social dimensions. Therefore, this type of 
biotech object, named HeLa, may be interpreted and imagined as an invisible 
infrastructure that interweaves sociotechnical connections, and at the same time it 
is able to involve human actors and technological objects as well. In this sense, 
Rebecca Skloot seems to have assumed in her rhetoric the theoretical challenges set 
by biotechnologies and elected as fieldworks by the Science and Technology 
Studies.  
The author, in little less than a four hundred page novel, tells us about her 
“vagrancy” across mental asylums, hospitals, clinical case histories, biopsies, 
research laboratories and Nobel prizes, swindlers, criminals and small shops, 
salesclerks. This type of research reminds us of what in the literature has been 
defined as multi-sited ethnography (Marcus, 1995) or, in more evocative terms, 
“vagrant ethnography” (Bruni, 2008); a vagrancy of ten years that has permitted 
the author to collect more than one thousand hours of conversation in order to 
provide an account which can make the “global and the cellular” communicate 
(Franklin and Lock, 2003). It should be noted that Skloot's study intersects the 
dimensions of gender, class and race. She deeply analyses the ways in which some 
white clinicians of the John Hopkins Centre dispossessed the body of a poor black 
woman, without informing her family – who discovered the fact after twenty-five 
years of experimentations on Henrietta's cells – and without asking for any kind of 
authorization. Therefore, one could argue that this dispossession of a portion of 
human tissue has been incredibly profitable in the production of biocapital from 
which where Henrietta's family has been excluded. 
The perspective which is used by the author – without succumbing to the 
rhetorical expedient of the inventor hero that characterizes the popular narrative 
about science and technology – confers rigour and profundity to the narrative 
structure; moreover, the author masterly put together the alignment processes and 
the relational ecology that characterize a particularly ‘technoscientific story’. 
Skloot's novel pays great attention to the definition of those asymmetrical powers 
that the North American culture and society harboured during the 1950's. The text 
reports an unusual story of a successful innovation by tracking the genealogical 
features and knots of the networks which have brought stabilization to a new 
biological object named HeLa.  
The author has chosen a rhetoric that might be comparable to what Latour 
defines as ‘infra-language’ (Latour, 2005). In this specific case, it is a description – 
using typical “coloured” words of the Afro-American vocabulary – which makes 
connections between knots and actors, and allows the reader to place him/herself 
within the processes and the activities of the construction of the network – that is 
from the cellular to the global.  
Skloot, by tracing the connections ranging from the cellular to the global, draws 




a multiform biopolitical geography where the reader can explore the mutual 
reshaping between human subjectivity, institutional arrangements and processes by 
which individuals and technologies assemble each other in technologically dense 
environments. The emerging outcome is a thick description of the connections and 
the development of an unknown phenomenon (immortalization of human bios) 
which in the STS debate is also defined as an "emergent form of life". According 
to Fischer, this concept identifies the cultural and symbolic morphology assumed 
by the social representations of life tout court (1999, 2003). In the end, the reader 
can grasp: firstly the interrelations between the different places where knowledge is 
produced; secondly the ethical and moral controversies; and finally the 
appropriation and valorisation mechanisms which, through specific political and 
cultural dynamics, have brought to the surface emergent forms of life.  
Rebecca Skloot's study explores and analyses the technoscientific social worlds 
with a vivid and smart narrative that I would define as STS Novel. This 
dramatically styled narrative is able to overturn the rigid canon that characterizes 
the scientific academic production and to stimulate new perspectives in social 
research in order to investigate the technoscientific social dimensions. This genre 
of writing could represent a style of inquiry that tacitly complies with multi-sited 
ethnography and defines a technoscientific history which is able to reflect all levels 
of the social, cultural and political theory. The main challenges and perspectives 
that an STS Novel offers are: firstly, the methodological implications, namely the 
need to adopt multi-local technique as a way to access the various strategic places 
of production and sharing of scientific knowledge; secondly, the possibility of 
using a mode of polyphonic representation of social phenomena, which restores 
the agency to all social actors and technologies involved within an ecology of 
relationships for mapping the situatedness of knowledge; finally, the chance to 
construct a multi-audience text which keeps rigor and precision, without 
dissolving in technological determinism, or reductionism, the complexity of the 
social investigation of technoscience. 
Arguably, this was certainly not the intention of the author. However, as usual, 
all the artefacts, books included, are constantly subjected to continuous processes 
of translation during their life time and circulation. What happens is a form of 
situated reconstruction and recontextualization through which the entities, ideas 
and artefacts acquire meaning through the relations with other entities, whether 
human or not. It is certainly true that the ideas which are contained in an 
abandoned book on one shelf cannot circulate. It is equally possible that a book 
that goes hand in hand acquires new energy and new meanings in virtue of the fact 
that social actors will change and adapt it to their research or intellectual project. 
To summarize, an STS Novel is a narrative multi-audience artefact, which sti-
mulates the reflexivity and deconstruction of technoscientific representations. Such 
a narrative artefact allows us to acknowledge a multiplicity of conflicting discursive 
reconstructions of social phenomena entering into a stream of representations. For 
this reason, it is important and desirable to juxtapose and integrate different genres 
of writing, thinking and working with historians, novelists, literary critics, science 












Bruni, A. (2008) Attivare e stabilizzare un network nel settore delle biotecnologie: il 
caso Tek-Tek, in S. Gherardi (ed.) Apprendimento tecnologico e tecnologie di 
apprendimento, Bologna, il Mulino, pp. 147-178. 
Fischer M.M.J. (1999) Emergent forms of Life: Anthropologies of Late or 
Postmodernities, in “Annual Review of Anthropology”, 29, pp. 455-478. 
Fischer M.M.J. (2003) Emergent Forms of Life and the Anthropological Voice, 
Durham - London, Duke University Press. 
Fleck, L. (1979) Genesis and Development of a Scientific Fact, Chicago, University 
of Chicago Press. 
Foucault, M. (1961) Histoire de la folie à l'âge classique, Paris, Gallimard 
Foucault, M. (2004) Naissance de la Biopolitique: Cours au Collège de France, 1978-
1979, Paris, Gallimard. 
Franklin, S. and Lock, M. (2003) Animation and Cessation: The Remaking of Life 
and Death, in S. Franklin and M. Lock (eds.) Remaking Life & Death: Toward 
an Anthropology of the Biosciences, Santa Fe and Oxford, School of American 
Research Press and James Currey, pp. 3-22. 
Haraway, D.J. (1997) Modest_Witness@Second_Millennium.FemaleMan ©_Meets_ 
OncoMouse™: Feminism and Technoscience, London, Routledge. 
Landecker, H. (2000) Immortality, in vitro: A History of the HeLa Cell Line, in P. 
Brodwin (ed.) Biotechnology and Culture: Bodies, Anxieties, Ethics, 
Bloomington, Indiana University Press, pp. 53-72. 
Latour, B. (2005) Reassembling the social: an introduction to actor-network-theory, 
Oxford, Oxford University Press. 
Littlefield, M.M. and Pollock A. (2011) Review essay: Troubling with ‘the ethics of 
the thing' in Culturing Life: How Cells Became Technologies and The Immortal 
Life of Henrietta Lacks, in “Social Studies of Science”, 41(4), pp. 609–618. 
Marcus, G. (1995) Ethnography in/of the World System: The Emergence of Multi-
Sited Ethnography, in “Annual Review of Anthropology”, 24, pp. 95-117. 
Skloot, R. (2010) The Immortal Life of Henrietta Lacks, New York, Crown 
Publishers. 
Star, S. L. (1999), The Ethnography of the Infrastructure, in “American Behavioural 
Scientist”, 43, pp. 111-134. 
Sunder Rajan, K. (2006) Biocapital: The Constitution of Postgenomic Life, Durham 
and London, Duke University Press.  
Tenney, L. D. (1934), Ko Hung (Pao P’u Tzu), Chinese alchemist of fourth century, 
in “Journal of Chemical Education”, 11, pp. 517-520. 




Turrini, M. (2011) Biotecnologie, salute e lavoro clinico, in M. Turrini (ed.) 
Biocapitale. Vita e corpi nell’era del controllo biologico, Verona, Ombre Corte, 
pp. 7-38. 
Waldby, C. and Mitchell, R. (2006) Tissue Economies: Organs, Blood and Cell Lines 






Sara Casati University of Milano Bicocca  
Department of Surgical Sciences 
Via Cadore, 48, 20052 Monza, Italy 	  
Email: sara.casati@unimib.it 
 
Stefano Crabu University of Padova 
PaSTIS - Department FISPPA 
Section of Sociology - Via M. Cesarotti, 10/12, 35123 Padova, Italy	  
Email: stefano.crabu@gmail.com 
 
Marialuisa Lavitrano University of Milano Bicocca  
Department of Surgical Sciences  
Via Cadore, 48 - 20052 Monza, Italy 	  
Email: marialuisa.lavitrano@unimib.it 
 
Mauro Turrini University of Padova 
PaSTIS - Department FISPPA 
Section of Sociology - Via M. Cesarotti, 10/12, 35123 Padova, Italy 
Email: mauro.turrini@unipd.it 	  	  
 
 
CONVERSATIONS 
 
162 
 
